mTOR inhibition induces compensatory, therapeutically targetable MEK activation in renal cell carcinoma.

Bailey ST, Zhou B, Damrauer JS, Krishnan B, Wilson HL, Smith AM, Li M, Yeh JJ, Kim WY
PLoS One. 2014 Sep 2;9(9):e104413. doi: 10.1371/journal.pone.0104413. eCollection 2014. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.